Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon IncfiledCriticalCephalon Inc
Publication of CL2014001265A1publicationCriticalpatent/CL2014001265A1/en
CL2014001265A2011-11-142014-05-14
Compounds derived from uracil, axl and c-met kinase inhibitors, useful in the treatment of cancer.
CL2014001265A1
(en)
Compounds derived from substituted pyrrolidine-2-carboxamides, mdm2 antagonists; pharmaceutical composition; and its use in the treatment or prophylaxis of cancer.
Compounds derived from 3-phenyl-isoquinolin-1 (2h) -one, parp-1 inhibitors; preparation procedure; pharmaceutical composition; and use in the treatment of cancer.